Next Gen Biotech
Mayapuri, New Delhi, Delhi
GST No. 07AAKFN5053A1ZK
08048982480 89% Response Rate
Send E-mail
- Home
- »
- Our Products
- »
- Anti Cancer Injection
| Brand | BRYXTA |
| Composition | Bevacizumab |
| Packaging | Vial |
| Manufacturer | Cadila Healthcare (Zydus) |
| Dosage Form | 400 mg/16 ml |
| Warning and Precaution | Not to be taken by Pregnant Women |
| Storage | 2 - 8 c |
| Country of Origin | Made in India |
| Packaging size | 5 ml |
| Brand | Fuvestrol |
| Composition | Fulvestrant |
| Manufacturer | Cadila |
| Prescription/Non prescription | Prescription |
| Form | Injection |
| Strength | 250 mg |
| Packaging size | 5 ml |
| Brand | Fulveser |
| Composition | Fulvestrant |
| Manufacturer | Samarth |
| Strength | 250 mg |
Fulvestrant Injection is used in combination with palbociclib, the recommended dose is 250 mg to be administered intramuscularly into the buttocks (gluteal area) slowly (1 - 2 minutes per injection) as two 5 mL injections, one in each buttock, on days 1, 15, 29 and once monthly thereafter. The recommended dose of palbociclib is a 125 mg capsule taken orally once daily for 21 consecutive days followed by 7 days off treatment to comprise a complete cycle of 28 days. Palbociclib should be taken with food. Please refer to the full prescribing information of palbociclib.
*Your information is safe with us.
| Minimum Order Quantity | 2 per vial |
| Manufacturer | CADILA |
| Storage | 25% - 30% |
| Prescription/Non prescription | Prescription |
| Shelf life | MINIMUM 3 YEARS |
| Composition | BORTEZOMIB |
| Brand | BORTECAD |
| Packaging Size | VIAL |
| Form | Injection |
| Deals in | ALL COMPANIES |
| Treatment | MULTIPLE MYELOMA |
| Dosage | 2MG/2.5MG |
| Country of Origin | Made in India |
| Manufacturer | MSN |
| Packaging Size | 1*7 TAB |
| Brand | PALBOREST |
| Prescription/Non prescription | Prescription |
| Form | Tablet |
| Deals in | Patient and Chemist |
| Treatment | BREAST CANCER |
Palbociclib is used to treat adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. It should always be used in combination with another medicine either:
| Packaging size | 4 ml |
| Brand | Abevmy |
| Composition | Bevacizumab |
| Manufacturer | Mylan |
| Prescription/Non prescription | Prescription |
| Strength | 100 mg |
*Your information is safe with us.
| Minimum Order Quantity | 2 vial |
| Packaging Size | VIAL |
| Manufacturer | Dr Reddy'S |
| Prescription/Non prescription | Prescription |
| Form | Injection |
| Packaging size | 16 Ml |
| Brand | Abevmy |
| Composition | Bevacizumab |
| Manufacturer | Mylan |
| Prescription/Non prescription | Prescription |
| Strength | 400 Mg |
| Manufacturer | Emcure |
| Packaging size | 5 ml |
| Brand | Fulvira |
| Composition | Fulvestrant |
| Prescription/Non prescription | Prescription |
| Strength | 250 mg |
| Treatment | BREAST CANCER |
*Your information is safe with us.
| Brand | MYGEM |
| Composition | Gemcitabine |
| Manufacturer | MYLAN |
| Packaging Type | Vial |
| Prescription/Non prescription | Prescription |
| Dose/Strength | 1,1.5 gm |
| Minimum Order Quantity | 1 Vial |
| Brand | MYGEM & GEMPOWER |
| Composition | GEMCITABINE |
| Manufacturer | K LABS & MYLAN |
| Prescription/Non prescription | Prescription |
| Packaging Type | VIAL |
| Packaging Size | 1GM & 200MG {RATE WILL BE NEGOTIABLE} |
| Form | Injection |
| Dose/Strength | 1GM |
| Country of Origin | Made in India |
| Packaging Size | 2 Mg |
| Brand | Myezom |
| Composition | Bortezomib Inj |
| Manufacturer | Dr'Reddy'S |
| Prescription/Non prescription | Prescription |